Multiple Sclerosis News and Research

Latest Multiple Sclerosis News and Research

Cedars-Sinai neurologist to study MS-related depression

Living every day with a life-changing illness is discouraging enough, but Maryam Hosseinzadeh is one of 400,000 people in the United States battling multiple sclerosis, a disorder that by changing the brain's makeup appears capable of generating the secondary ill of depression.

21 Sep 2012

Close monitoring could give early warning of MS disease course

Patients with multiple sclerosis who have breakthrough disease activity early in the course of treatment with interferon beta-1a are at high risk for severe worsening and poor long-term outcomes, research shows.

20 Sep 2012

Bionic legs: an interview with Rob Cripe, SVP of Marketing from Tibion

The Bionic Leg is a wearable robotic trainer that is used on mobility impaired patients who need to relearn how to use their affected limb. It is used by clinicians as a tool that is designed to help strengthen stance, improve gait and enhance active motor learning.

19 Sep 2012

Longer looks: The smells to treat PTSD; Nudging healthy choices; When a disabled daughter was shunned

On an Orlando college campus, veterans and active duty soldiers suffering from post-traumatic stress disorder inhale the unmistakable smell of burning tires, rotting garbage and Middle Eastern spices as part of a virtual reality treatment for the psychological wounds of war. Participants sit in a chair wearing a head-mounted display and video goggles connected to a computer system and a scent machine that puffs out the odors, recreating their memories of war.

14 Sep 2012

Multiple interventions improve medication adherence for patients with chronic conditions

Although patients with chronic conditions who do not take medications as prescribed tend to have poorer health outcomes and higher health care costs than those who adhere to medication regimens, a new report sheds light on the potential for multiple interventions to improve medication adherence.

13 Sep 2012

Kessler Foundation’s two-day conference on brain injury to be held from Sep. 27-28

A two-day conference, "Brain Injury: From Research to Rebuilding Lives", will be held on September 27th and 28th at Kessler Institute for Rehabilitation in West Orange, NJ.

13 Sep 2012

Sanofi Aventis receives FDA approval for Aubagio to treat relapsing forms of MS

The U.S. Food and Drug Administration today approved Aubagio (teriflunomide), a once-a-day tablet for the treatment of adults with relapsing forms of multiple sclerosis (MS).

13 Sep 2012

Genzyme receives FDA approval for AUBAGIO to treat relapsing forms of MS

Genzyme, a Sanofi company, announced today that the U.S. Food and Drug Administration (FDA) has approved AUBAGIO (teriflunomide) as a new once-daily, oral treatment indicated for patients with relapsing forms of multiple sclerosis (MS).

13 Sep 2012

Bioengineers design nanoparticles that can safely and predictably infiltrate deep into the brain

The brain is a notoriously difficult organ to treat, but Johns Hopkins researchers report they are one step closer to having a drug-delivery system flexible enough to overcome some key challenges posed by brain cancer and perhaps other maladies affecting that organ.

12 Sep 2012

Genes predict the brain's reaction to smoking

Have you ever wondered why some people find it so much easier to stop smoking than others? New research shows that vulnerability to smoking addiction is shaped by our genes. A study from the Montreal Neurological Institute and Hospital - The Neuro, McGill University shows that people with genetically fast nicotine metabolism have a significantly greater brain response to smoking cues than those with slow nicotine metabolism.

12 Sep 2012

Ginkgo biloba supplements fail to improve cognitive performance in multiple sclerosis

A research study conducted by Dr. Jesus Lovera, Assistant Professor of Neurology at LSU Health Sciences Center New Orleans, and colleagues has found that the herbal supplement Ginkgo biloba does not improve cognitive function in patients with Multiple Sclerosis (MS).

12 Sep 2012

BRI scientists receive two major grant awards for research into autoimmunity prevention

Benaroya Research Institute at Virginia Mason (BRI) recently received two major grant awards to explore how to regulate the immune system, as part of a nationwide collaborative program to prevent autoimmune diseases.

11 Sep 2012

Combining two drugs may offer new and potent punch against cancer and other diseases

A new study by researchers at Weill Cornell Medical College shows combining two already-FDA approved drugs may offer a new and potent punch against diseases in which blood vessel growth is abnormal -- such as cancer, diabetic retinopathy, macular degeneration and rheumatoid arthritis.

11 Sep 2012

Researchers identify three genetic regions associated with primary biliary cirrhosis

Researchers have newly identified three genetic regions associated with primary biliary cirrhosis (PBC), the most common autoimmune liver disease, increasing the number of known regions associated with the disorder to 25.

10 Sep 2012

New strategy will have positive impact on people with brain disorders

New research offers a possible strategy for treating central nervous system diseases, such as brain and spinal cord injury, brain cancer, epilepsy, and neurological complications of HIV. The experimental treatment method allows small therapeutic agents to safely cross the blood-brain barrier in laboratory rats by turning off P-glycoprotein, one of the main gatekeepers preventing medicinal drugs from reaching their intended targets in the brain.

10 Sep 2012

Bionic leg activated by patient’s intent to move introduced by Tibion

Patients who can't use their legs from the effects of multiple sclerosis, stroke, traumatic brain injury, partial spinal cord injury and other debilitating conditions have been given a new 'leg up' with the introduction of the only wearable, lower limb, robotic trainer activated by the patient's intent to move - the Tibion Bionic Leg.

7 Sep 2012

Hebrew University researcher develops anti-inflammatory and anti-allergic family of drugs

A synthetic, anti-inflammatory and anti-allergic family of drugs to combat a variety of illnesses while avoiding detrimental side effects has been developed by a Hebrew University of Jerusalem researcher.

7 Sep 2012

Absence of Puma and Bim protein leads to autoimmune diseases

Researchers at the Walter and Eliza Hall Institute have discovered that a pair of molecules work together to kill so-called 'self-reactive' immune cells that are programmed to attack the body's own organs.

7 Sep 2012

Preliminary research findings from Kessler Foundation’s Ekso device study on SCI

Kessler Foundation has released preliminary research findings from its clinical study of the wearable robotic exoskeletal device, Ekso. Gail Forrest, PhD, assistant director of Human Performance and Engineering Research, presented the Ekso research data on September 3, at the meeting of the Academy of Spinal Cord Injury Professionals at the Rio Suites in Las Vegas. Dr. Forrest directs mobility research at the Foundation, including activity-based locomotor therapy, functional electrical stimulation, and treadmill training with the LokomatPro v6, as well as Ekso.

6 Sep 2012

Merck, Symphogen announce worldwide license agreement for Sym004 to treat cancers

Symphogen A/S, a private biopharmaceutical company developing recombinant antibody mixtures, a class of antibody therapeutics under investigation for the treatment or prophylaxis of serious human diseases such as cancer or infectious and autoimmune diseases, today announced that an exclusive worldwide license agreement was signed with Merck KGaA, Darmstadt, Germany, for Sym004, an investigational antibody mixture targeting the epidermal growth factor receptor (EGFR).

6 Sep 2012

Multiple Sclerosis News and Research

Latest Multiple Sclerosis News and Research

Cedars-Sinai neurologist to study MS-related depression

Close monitoring could give early warning of MS disease course

Bionic legs: an interview with Rob Cripe, SVP of Marketing from Tibion

Longer looks: The smells to treat PTSD; Nudging healthy choices; When a disabled daughter was shunned

Multiple interventions improve medication adherence for patients with chronic conditions

Kessler Foundation’s two-day conference on brain injury to be held from Sep. 27-28

Sanofi Aventis receives FDA approval for Aubagio to treat relapsing forms of MS

Genzyme receives FDA approval for AUBAGIO to treat relapsing forms of MS

Bioengineers design nanoparticles that can safely and predictably infiltrate deep into the brain

Genes predict the brain's reaction to smoking

Ginkgo biloba supplements fail to improve cognitive performance in multiple sclerosis

BRI scientists receive two major grant awards for research into autoimmunity prevention

Combining two drugs may offer new and potent punch against cancer and other diseases

Researchers identify three genetic regions associated with primary biliary cirrhosis

New strategy will have positive impact on people with brain disorders

Bionic leg activated by patient’s intent to move introduced by Tibion

Hebrew University researcher develops anti-inflammatory and anti-allergic family of drugs

Absence of Puma and Bim protein leads to autoimmune diseases

Preliminary research findings from Kessler Foundation’s Ekso device study on SCI

Merck, Symphogen announce worldwide license agreement for Sym004 to treat cancers

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Multiple Sclerosis News and Research

Latest Multiple Sclerosis News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in